Opioids
During the past two years, the health care field has been focused on fighting COVID-19…as it should be. Yet at the same time, another crisis surges.
Organizations can apply through July 29 for a portion of $10 million in funding to expand access to medication-assisted treatment for opioid use disorder in rural communities, the HRSA announced.
Reduce barriers to naloxone access. Put it in the hands of patients, families, friends, law enforcement officers and anyone hoping for the chance to be a Good Samaritan.
The agency seeks comments through June 21 on a potential change that would require outpatient settings to dispense opioid pain medications with prepaid mail-back envelopes and pharmacists to provide patient education on safe disposal of opioids.
In this webinar, Hazelden Betty Ford’s Stephen Delisi, MD, will examine the growing rates of substance use disorder and the impact of opioids and fentanyl on communities through his role consulting with health systems and medical professionals across the country. To focus on one health system’s…
The Substance Abuse and Mental Health Services Administration announced $25.6 million in grants to expand access to medication-assisted treatment for opioid use disorder and prevent the misuse of prescription drugs.
The Centers for Disease Control and Prevention is accepting comments through April 11 on a draft updated clinical practice guideline for prescribing opioids for chronic pain.
The Department of Health and Human Services announced a standard clinical definition for opioid withdrawal in infants. Recently published in the Journal of Pediatrics, the definition includes prenatal exposure and at least two of the most common clinical signs of withdrawal (excessive crying,…
The AHA voiced support for the Opioid Treatment Access Act (H.R. 6279), bipartisan legislation that would take steps to facilitate patients’ access to methadone treatment for opioid use disorder.
AHA letter to Representative Donald Norcross expressing support for bipartisan legislation, the Opioid Treatment Access Act (H.R. 6279).